Aethlon Medical - Stock Price History | AEMD

Historical daily share price chart and data for Aethlon Medical since 2020 adjusted for splits. The latest closing stock price for Aethlon Medical as of April 06, 2020 is 1.31.
  • The all-time high Aethlon Medical stock closing price was 11.38 on July 24, 2015.
  • The Aethlon Medical 52-week high stock price is 6.89, which is 426% above the current share price.
  • The Aethlon Medical 52-week low stock price is 0.20, which is 84.7% below the current share price.
  • The average Aethlon Medical stock price for the last 52 weeks is 1.33.
Aethlon Medical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.1163 1.5800 4.9900 0.2200 0.9630 -41.99%
2018 1.2869 1.1600 1.9000 0.9335 1.6600 46.90%
2017 2.1995 4.0180 4.7500 0.8010 1.1300 -73.10%
2016 5.3775 6.3000 7.7000 4.1100 4.2000 -38.14%
2015 7.6838 8.9400 11.3800 6.1700 6.7900 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.012B $0.000B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $217.688B 15.19
Anthem (ANTM) United States $51.260B 10.47
Humana (HUM) United States $38.531B 16.35
Centene (CNC) United States $32.040B 12.35
Molina Healthcare (MOH) United States $8.040B 11.31
Select Medical Holdings (SEM) United States $1.612B 9.68
Magellan Health (MGLN) United States $1.031B 11.19
Triple-S Management (GTS) United States $0.284B 4.62
Joint (JYNT) United States $0.123B 38.48